Ablative Solutions Stock
Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
Sign up today and learn more about Ablative Solutions Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Ablative Solutions Stock
Ablative Solutions, Inc., was founded in 2011 by Tim Fischell, MD, FACC, and David Fischell, PhD, to address this significant unmet medical need. Ablative Solutions’ technology involves endovascular catheters to provide an efficacious, durable, cost-effective and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.
Funding History
| January 2012 | $5K |
|---|---|
| March 2012 | $3.1M |
| June 2012 | $5.3M |
| March 2013 | $8.0M |
| February 2014 | $9.6M |
| January 2015 | $14.6M |
| November 2015 | $2.5M |
| January 2019 | $77.0M |
Management
Founder
David R. Fischell
CEO & CMO, Board of Directors
Tim Fischell
President & COO, Board of Directors
Vartan Ghazarossian
Press
Forbes - Feb, 5 2019
Healthcare Venture Capital Funding Is Off To A Record Start In 2019EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
